Edwards Lifesciences (EW) Share-based Compensation (2016 - 2025)
Edwards Lifesciences has reported Share-based Compensation over the past 17 years, most recently at $39.2 million for Q4 2025.
- Quarterly results put Share-based Compensation at $39.2 million for Q4 2025, up 23.66% from a year ago — trailing twelve months through Dec 2025 was $158.1 million (down 2.59% YoY), and the annual figure for FY2025 was $158.1 million, down 2.59%.
- Share-based Compensation for Q4 2025 was $39.2 million at Edwards Lifesciences, down from $41.2 million in the prior quarter.
- Over the last five years, Share-based Compensation for EW hit a ceiling of $44.6 million in Q1 2024 and a floor of $24.2 million in Q4 2021.
- Median Share-based Compensation over the past 5 years was $34.4 million (2022), compared with a mean of $34.8 million.
- Biggest five-year swings in Share-based Compensation: increased 29.14% in 2024 and later fell 14.58% in 2025.
- Edwards Lifesciences' Share-based Compensation stood at $24.2 million in 2021, then rose by 15.29% to $27.9 million in 2022, then grew by 9.32% to $30.5 million in 2023, then grew by 3.93% to $31.7 million in 2024, then rose by 23.66% to $39.2 million in 2025.
- The last three reported values for Share-based Compensation were $39.2 million (Q4 2025), $41.2 million (Q3 2025), and $37.5 million (Q2 2025) per Business Quant data.